Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Improving the Production of Self-Assembling Fibers and Peptide Hydrogels for Superior Biocompatibility
Published on: September 6, 2024
Injectable self-assembled peptide hydrogels for glucose-mediated insulin delivery
Mian Fu1, Chenyu Zhang, Yuxuan Dai
1State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, PR China. qianhai24@163.com.
This study presents a novel glucose-responsive insulin delivery system using a peptide hydrogel. The system effectively regulates blood glucose in diabetic rats for 8 days, offering potential for improved diabetes management.
Area of Science:
- Biomaterials Science
- Endocrinology
- Drug Delivery Systems
Background:
- Diabetes mellitus poses a significant health burden, necessitating advanced therapeutic strategies.
- Current insulin delivery methods often lack precise glucose responsiveness, leading to suboptimal glycemic control.
- Biocompatible, closed-loop systems are crucial for improving the quality of life for diabetic patients.
Purpose of the Study:
- To develop a glucose-responsive peptide hydrogel for automated insulin delivery.
- To investigate the hydrogel's pH-sensitivity and insulin release kinetics.
- To evaluate the in vivo efficacy of the closed-loop system in a diabetic rat model.
Main Methods:
- Fabrication of a pH-sensitive peptide hydrogel self-assembled under physiological conditions.
- Loading of insulin and a glucose-specific enzyme into the peptide carrier.
- In vitro and in vivo characterization, including structural, rheological, and release studies.
- Assessment of blood glucose regulation in streptozotocin-induced diabetic rats.
Main Results:
- The peptide hydrogel demonstrated pH-sensitive disassembly upon glucose-induced acid production.
- Controlled and consistent insulin release was observed in vitro.
- In vivo studies showed efficient blood glucose regulation in diabetic rats for up to 8 days.
Conclusions:
- The developed glucose-responsive peptide hydrogel system enables closed-loop insulin delivery.
- This innovative system shows significant potential for improving glycemic control in type 1 diabetes.
- The system's biocompatibility and prolonged efficacy highlight its therapeutic promise.
More Related Videos
09:39Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Peptide Bonds
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Insulin Secretory Vesicles